Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01447083Case File
efta-efta01447083DOJ Data Set 10CorrespondenceEFTA Document EFTA01447083
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01447083
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Description
Trade Date
Quantity
Last Prices Unit Cost
Market Value
Unrealized G/L
SANGAMO BIOSCIENCES
05/28/2013
50,000.00
$
19.80
$
8.44
$
990,000.00
$
567,786.00
BIOGEN
02/14/2012
2,095.00
$
312.60
$
119.55
$
654,897.00
$
404,442.05
FOUNDATION MEDICINE
01/13/2014
25,000.00
$
36.40
$
27.51
910,000.00
$
222,336.50
GILEAD SCIENCES INC
2/5/14, 3/7/14
8,100.00
$
72.13
$
79.41
$
584,253.00
$
(58,951.00)
ARIAD PHARMACEUTICALS
2/14/12, 1/24/13
16,535.00
$
7.60
$
17.60
$
125,666.00
$ (165,331.40)
Total Biotec $3,264,816.00
$ 970,282.15
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
CONFIDENTIAL
DB-SDNY-0101588
SDNY_GM_00247772
EFTA01447083
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.